Development, Characterization & Comparative Evaluation of Nanostructured Lipid Carriers and Solid Lipid Nanoparticles for Potent Oral Delivery of Furosemide

Journal Title: Saudi Journal of Medical and Pharmaceutical Sciences - Year 2018, Vol 4, Issue 11

Abstract

The aim of the present study was to increase the solubility and thereby improve the oral bioavailability of Furosemide by incorporating the drug in nanostructured lipid carriers (NLC) and in solid lipid nanoparticle (SLN) and also to compare the efficiency of NLC over SLN. Both the NLC and SLN were prepared by solvent diffusion method using labrafil m 2130 as solid lipid, capryol pgmc as liquid lipid, and tween 80 as surfactant. Properties of Furosemide loaded NLCs & SLNs such as drug content, entrapment efficiency, loading capacity, particle size, PDI , zeta potential, morphology, storage stability, in vitro drug release and mechanism of drug release were investigated and compared. Drug content, entrapment efficiency, loading capacity, average particle size, PDI and zeta potential of Furosemide NLC were found to 83.56%, 75.50%, 25.63%, 99.24nm, 0.302 and -31.2mV and that of Furosemide SLN were found to 84.55%, 71.07%, 24.62%, 193.4nm, 0.835 and -36.1mV respectively. Morphology study by scanning electron microscopy (SEM) analysis showed spherical particles with smooth surfaces. As compared to in-vitro drug release of Furosemide pure drug, both the NLC and SLN showed fast initial release followed by a sustained release, best fitted to Higuchi equation. Pure drug followed Zero order release kinetics. Furosemide NLC showed higher entrapment efficiency, drug loading capacity, in-vitro drug release, reduced the drug expulsion in storage when compared to SLN. This investigation demonstrated the efficiency of NLC over SLN for improved oral bioavailability of Furosemide and it was deduced that the liquid lipid (capryol pgmc)was the principal formulation factor responsible for the improvement in characteristics and pharmacokinetics of NLCs.

Authors and Affiliations

Anurughma S, Mrs. Neema George

Keywords

Related Articles

Analytical Method Development and Validation for the Estimation of Rosuvastatin Calcium in Raw Material and Tablet Formulation by UV Spectrometric Method

Abstract: Statins are the treatment of choice for controlling hypercholesterolemia in patients with cardiovascular risk. Although all statins are HMG-CoA reductase inhibitors, they possess different chemical structure, p...

Formulation and Evaluation of Colon Targeted pH Dependent Microcapsules of Thymoquinone for Colorectal Cancer

Abstract:Aim of the present work was to prepare the colon-targeting pH dependent microcapsules of Thymoquinone for the treatment of colorectal cancer. pH dependent polymer Eudragit L100,and S100 were used to formulate th...

In-Vitro Antitubercular Activity of Some Novel 6-Substituted/ Unsubstituted-2-Phenyl-Quinoline Derivatives

With an objective to develop some potent, novel and less side effect having antitubercular agents here we have synthesized a series of substituted/ unsubstituted 2-phenyl tetrahydroquinoline derivatives (IIa-g). These we...

Topical Medications and Dosage Specificity: Somatotype and Anatomical Body Girths as Correlates and Predictors of Finger Tip Units Metric Length

Abstract: Finger Tip Unit (FTU) is being considered as a means of quantifying dosages but rough guides are provided in literature and it is without psychometric value. The primary aims of this study were to determine ref...

Melkersson-Rosenthal Syndrome about a Case

Abstract:Melkersson Rosenthal Syndrome (SMR) is a rare orofacialgranulomatosis of controversial etiology. It combines recurrent facial palsy, upper labial edema and a plicated tongue.Through a case of SMR we recall the c...

Download PDF file
  • EP ID EP488027
  • DOI -
  • Views 123
  • Downloads 0

How To Cite

Anurughma S, Mrs. Neema George (2018). Development, Characterization & Comparative Evaluation of Nanostructured Lipid Carriers and Solid Lipid Nanoparticles for Potent Oral Delivery of Furosemide. Saudi Journal of Medical and Pharmaceutical Sciences, 4(11), 1269-1285. https://europub.co.uk/articles/-A-488027